Covid and Viral Persistence

Covid and Viral Persistence

55 bookmarks
Custom sorting
Evidence is now clear from scientists in the field that this virus persists and even quietly replicates in the colon for years
Evidence is now clear from scientists in the field that this virus persists and even quietly replicates in the colon for years

“Evidence is now clear from scientists in the field that this virus persists and even quietly replicates in the colon for years The question we are beginning to answer: is this virus oncogenic meaning can it lead to cancer in years to come?”

·x.com·
Evidence is now clear from scientists in the field that this virus persists and even quietly replicates in the colon for years
Here is the first randomized trial to show that an antiviral can prevent Long Covid.
Here is the first randomized trial to show that an antiviral can prevent Long Covid.

“Here is the first randomized trial to show that an antiviral can prevent Long Covid.

In the PANORAMIC trial, people randomized to molnupiravir had less risk of Long Covid than people who received no antivirals

My comment in the link below. A short🧵”

·x.com·
Here is the first randomized trial to show that an antiviral can prevent Long Covid.
SARS-CoV-2 antivirals and post-COVID-19 condition
SARS-CoV-2 antivirals and post-COVID-19 condition
“Because SARS-CoV-2 itself is the causative agent of long COVID and because viral persistence is postulated to play a major role in the pathogenesis of the condition, antivirals, which block viral replication, were seen as potential candidates for the prevention and treatment of long COVID.”
Because SARS-CoV-2 itself is the causative agent of long COVID and because viral persistence is postulated to play a major role in the pathogenesis of the condition, antivirals, which block viral replication, were seen as potential candidates for the prevention and treatment of long COVID.
·thelancet.com·
SARS-CoV-2 antivirals and post-COVID-19 condition
"The use of antivirals to reduce the risk of long COVID is grounded in the hypothesis that viral persistence and possible ongoing replication of SARS-CoV-2 are major mechanistic pathways responsible for long COVID..
"The use of antivirals to reduce the risk of long COVID is grounded in the hypothesis that viral persistence and possible ongoing replication of SARS-CoV-2 are major mechanistic pathways responsible for long COVID..

Literally living WITH Covid.

The use of antivirals to reduce the risk of long COVID is grounded in the hypothesis that viral persistence and possible ongoing replication of SARS-CoV-2 are major mechanistic pathways responsible for long COVID

·x.com·
"The use of antivirals to reduce the risk of long COVID is grounded in the hypothesis that viral persistence and possible ongoing replication of SARS-CoV-2 are major mechanistic pathways responsible for long COVID..
Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review
Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review

ANTIVIRAL THERAPIES FOR PERSISTENT COVID/LONG COVID 83% SUCCESS 70 of 84 cases with the aggravating factor of immunosuppression

The types of treatment were grouped into: Prolonged Antiviral therapy Combination Antivirals Mixed therapy: Antiviral +Antibody

·onlinelibrary.wiley.com·
Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review
Hey, folks. The Chinese government woke up years ago with the repurposing of Azvudine, producing nine billion pills that protected the thymus of their population and specifically targets HIV's Vif protein, preserving the CD4 population. The West chose to rot. End of story.
Hey, folks. The Chinese government woke up years ago with the repurposing of Azvudine, producing nine billion pills that protected the thymus of their population and specifically targets HIV's Vif protein, preserving the CD4 population. The West chose to rot. End of story.

Thread: Hey, folks. The Chinese government woke up years ago with the repurposing of Azvudine, producing nine billion pills that protected the thymus of their population and specifically targets HIV's Vif protein, preserving the CD4 population. The West chose to rot. End of story.

·x.com·
Hey, folks. The Chinese government woke up years ago with the repurposing of Azvudine, producing nine billion pills that protected the thymus of their population and specifically targets HIV's Vif protein, preserving the CD4 population. The West chose to rot. End of story.
MENSA, a Media Enriched with Newly Synthesized Antibodies, to Identify SARS-CoV-2 Persistence and Latent Viral Reactivation in Long-COVID
MENSA, a Media Enriched with Newly Synthesized Antibodies, to Identify SARS-CoV-2 Persistence and Latent Viral Reactivation in Long-COVID

Among other findings of this study, reactivation of viral herpes (EBV/CMV/HSV2) and CONFIRMED PERSISTENT SARS-CoV-2 INFECTIONS

This study is really about the diagnostic tool, and confirmation of viral persistence was part of proving the tool works. This is a step in the direction of a SarsCov2 test similar to HIV test.

·medrxiv.org·
MENSA, a Media Enriched with Newly Synthesized Antibodies, to Identify SARS-CoV-2 Persistence and Latent Viral Reactivation in Long-COVID
Infective SARS-CoV-2 in Skull Sawdust at Autopsy, Finland
Infective SARS-CoV-2 in Skull Sawdust at Autopsy, Finland

New study shows #SARSCoV2 in skull sawdust at autopsy in 22 deceased persons with confirmed #COVID19.

by PCR (2/22, 9.1%) and by culture (1/22, 4.5%) in skull sawdust, suggesting that live virus is present in tissues postmortem, including bone.

·wwwnc.cdc.gov·
Infective SARS-CoV-2 in Skull Sawdust at Autopsy, Finland
‘Visionary’ study finds inflammation, evidence of Covid virus years after infection
‘Visionary’ study finds inflammation, evidence of Covid virus years after infection
Investigators found long-lasting immune activation months and even years after infection. And, even more concerning, they report what looked like lingering SARS-CoV-2 virus in participants’ guts. Even those who’d had Covid but no continuing symptoms had different results than those who’d never been infected.
Investigators found long-lasting immune activation months and even years after infection. And, even more concerning, they report what looked like lingering SARS-CoV-2 virus in participants’ guts. Even those who’d had Covid but no continuing symptoms had different results than those who’d never been infected.
·statnews.com·
‘Visionary’ study finds inflammation, evidence of Covid virus years after infection
Presence of SARS‐CoV‐2 RNA in COVID‐19 survivors with post‐COVID symptoms 2 years after hospitalization: The VIPER study
Presence of SARS‐CoV‐2 RNA in COVID‐19 survivors with post‐COVID symptoms 2 years after hospitalization: The VIPER study
The SARS-CoV-2 VIrus PERsistence (VIPER) study investigated the presence of long-lasting SARS-CoV-2 RNA in plasma, stool, urine, and nasopharyngeal samples in COVID-19 survivors.
The SARS-CoV-2 VIrus PERsistence (VIPER) study investigated the presence of long-lasting SARS-CoV-2 RNA in plasma, stool, urine, and nasopharyngeal samples in COVID-19 survivors.
·onlinelibrary.wiley.com·
Presence of SARS‐CoV‐2 RNA in COVID‐19 survivors with post‐COVID symptoms 2 years after hospitalization: The VIPER study
The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China
The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China
Our findings suggest that residual SARS-CoV-2 can persist in patients who have recovered from mild COVID-19 and that there is a significant association between viral persistence and long COVID symptoms.
Our findings suggest that residual SARS-CoV-2 can persist in patients who have recovered from mild COVID-19 and that there is a significant association between viral persistence and long COVID symptoms.
·thelancet.com·
The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China
The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China
The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China
Our findings suggest that residual SARS-CoV-2 can persist in patients who have recovered from mild COVID-19 and that there is a significant association between viral persistence and long COVID symptoms.
·thelancet.com·
The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China
COVID-19 Virus Can Persist in the Body More Than a Year after Infection - PolyBio Research Foundation
COVID-19 Virus Can Persist in the Body More Than a Year after Infection - PolyBio Research Foundation
“The fact that every new SARS-CoV-2 infection has the potential to become chronic is perhaps the single most concerning aspect of this virus” says Dr. Amy Proal, President of PolyBio. “We have compelling data that viral persistence is much more common than recognized, which could have major health implications.”
·polybio.org·
COVID-19 Virus Can Persist in the Body More Than a Year after Infection - PolyBio Research Foundation
Early Biological Markers of Post-Acute Sequelae of SARS-CoV-2 Infection
Early Biological Markers of Post-Acute Sequelae of SARS-CoV-2 Infection

These patients were given a monoclonal antibody to tag viral RNA, then sent through a PET scanner for imaging to show the persistence. Even patients that didn't have long cov*d had viral RNA. #viral persistence

·medrxiv.org·
Early Biological Markers of Post-Acute Sequelae of SARS-CoV-2 Infection
Use of total-body PET imaging to identify deep-tissue SARS-CoV-2 viral reservoirs and T cell responses in patients with Long COVID - PolyBio Research Foundation
Use of total-body PET imaging to identify deep-tissue SARS-CoV-2 viral reservoirs and T cell responses in patients with Long COVID - PolyBio Research Foundation
USE OF TOTAL-BODY PET IMAGING TO IDENTIFY DEEP-TISSUE SARS-COV-2 VIRAL RESERVOIRS AND T CELL RESPONSES IN PATIENTS WITH LONG COVID
·polybio.org·
Use of total-body PET imaging to identify deep-tissue SARS-CoV-2 viral reservoirs and T cell responses in patients with Long COVID - PolyBio Research Foundation
laurie allee on Twitter
laurie allee on Twitter

AMAZING STUDY : MULTIPLE OMICRON SUB-VARIANTS in MULTIPLE TISSUE locations,

such as the lungs, heart, liver, kidneys, and intestines, both after primary infection and after reinfections

·twitter.com·
laurie allee on Twitter